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cells by reporter ﬂuorescence that is initiated by intracellular
enzyme action; only three distinct cancer-linked enzymes have
been targeted to date.5−7 Enzyme-initiated dequenching of
probe ﬂuorescence has been used to improve the signal-tobackground value of the resulting reporter in diseased
(positive) cells in comparison to that of unactivated probe or
unaﬀected (negative) cells. Probe ﬂuorescence is quenched via
ﬂuorescence resonance energy transfer (FRET) or photoinduced electron-transfer (PeT) mechanisms, and reporter
ﬂuorescence comes about by enzyme-initiated disassociation of
the FRET quencher/donor pair upon enzyme binding7 or
cleavage of the quencher (trigger group) from the probe.5,6
However, modest signal-to-background (SBR)/positive-tonegative (PNR) or tumor-to-background (TBR) ratios have
been reported.5,6
Ideal probe characteristics include rapid cell uptake and
highly selective activation to yield the reporter, low
ﬂuorescence eﬃciency (Φprobe) of the unactivated probe but
high ﬂuorescence eﬃciency of the reporter (Φreport), and highquality retention of the reporter inside the diseased cells.
Furthermore, the probe−reporter pair will exhibit large
vs λreport
diﬀerences in energies of absorption maxima (λprobe
abs
abs )
probe
report
and emission maxima (λemis vs λemis ), so signiﬁcantly
enhanced PNR/TBR values arise from the low absorptivity of
the probe at the reporter’s maximum excitation wavelength.
A highly promising approach that incorporates many of the
above desired probe/reporter qualities is one wherein the probe
is tripartite, being composed of a self-immolative linker8
between the enzyme substrate/trigger group and the reporter
moiety in the ﬂuorescently silent probe. As a result of enzyme
activation, the trigger group is ﬁrst removed, and then the selfimmolative linker is autonomously eliminated to yield the now
highly ﬂuorescent reporter. It is anticipated that by the careful
selection of linker characteristics, the optical properties of the
probe can be made distinct from those of the reporter, and the
linker can be quickly cleaved from the reporter subsequent to
trigger group activation.
To that end, we developed probe 1,9 consisting of a
trimethyl-locked quinone propionic acid (Q3PA) trigger
group10 linked to a ﬂuorescently masked naphthalimide
(reporter 2) by N-methyl-p-aminobenzyl alcohol, NMPABA.
The Q3PA trigger group was selected due to its known rapid
and highly selective reduction10 by NAD(P)H:quinone
oxidoreductase-1 (NQO1),11,12 an enzyme intimately associated with cancer13 and overexpressed 2- to 50-fold in the

ABSTRACT: A frontier area in the development of
activatable (turn-on) ﬂuorescence-based probes is that
concerned with rapid and selective stimulus triggering of
probe activation so as to allow for biomarker identiﬁcation
and cellular imaging. The work here is concerned with a
cloaked ﬂuorophore composed of a reporter whose
ﬂuorescence is eﬃciently quenched by it being bound to
an activatable trigger group through a novel selfimmolative linker. Highly selective and rapid activation
of the trigger group is achieved by chemical and enzymatic
means that result in activated trigger group detachment
from the self-immolative linker, with the latter subsequently cleaved from the reporter autonomously,
thereby unmasking intense, red-shifted ﬂuorescence
emission. To achieve this success, we used a trimethyllocked quinone propionic acid trigger group and an Nmethyl-p-aminobenzyl alcohol self-immolative linker attached to the reporter. Delineated here are the synthesis
and characterization of this cloaked ﬂuorophore and the
evaluation of its triggered turning on in the presence of an
up-regulated enzyme in human cancer cells, NAD(P)H:quinone oxidoreductase-1 (NQO1, DT-diaphorase, EC
1.6.99.2).
he success of the ever-growing ﬁeld of in vivo and ex vivo
ﬂuorescence imaging of diseased cells for diagnosis,
pathology, and treatment applications rests upon the existence
of disease-speciﬁc molecules whose spectroscopic signal is
readily diﬀerentiated from that of the background of
surrounding normal cells.1 Molecular probes whose cloaked
ﬂuorescence reporter signal is turned on by endogenous
enzymes oﬀer distinct advantages over always-on reporters, in
particular, higher signal-to-background (positive-to-negative)
values.2 Critical for cancer imaging is the development of
libraries of turn-on probes that will allow for the collection of
real-time information on the diseased tissue cell microenvironment and the high-ﬁdelity deﬁnition of diseased and healthy
tissue borders during ﬂuorescence-assisted surgical resections.3−5
Unfortunately, the number of pro-ﬂuorogenic probes that
can have their ﬂuorescence output selectively and quickly
revealed by the presence of cancer-associated enzyme is
extremely small, as is the type of disease-associated activating
enzyme. Also, routes to improving the positive-to-negative
value are limited. There are three extant probes that passively
target cancer cells and rapidly (<30 min) identify the diseased
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the naphthalimide reporter by the Q3PA group. This
conclusion is supported by outcomes based on voltammetric
and spectroscopic data for probe 1, reporter 2, and Q3PA;9 the
free energy of the PeT process is −0.98 eV, indicating ready
electron transfer from the excited naphthalimide to the
electron-poor Q3PA group of probe 1. In comparison to the
previously reported probe Q3NI,5 there is a 3-fold-larger change
in ﬂuorescence eﬃciency for probe 1 upon NQO1 action to
yield the corresponding reporter (Φreport/Φprobe), and the
ﬂuorescence energy range of reporter 2 is more attractive for
possible imaging applications.
We next wanted to demonstrate rapid turning on of reporter
2 by the self-immolative cleavage of the NMPABA linker
subsequent to the reduction of probe 1. Dithionite reduction of
the Q3PA moiety is complete within 1 s, and the half-life of the
lactonization reaction is less than 2 min.16 Thus, sodium
dithionite was added to aqueous solutions of probe 1, and the
resulting ﬂuorescence from reporter 2 was used to determine
the extent of probe 1 conversion to reporter 2 (Figure 2).

Scheme 1. Turn-On Self-Immolative Proﬂuorophore 1

cytosol of numerous human tumor cells (e.g., colon, breast,
pancreas, and nonsmall cell lung).11 The previously unreported
NQO1-selective, turn-on ﬂuorescence probe 1 relies on tuning
the push−pull internal charge transfer (ICT)14 of the
naphthalimide scaﬀold via its attachment to the self-immolative
NMPABA linker using an electron-withdrawing carbamate
connection. We show here that upon initiation of trigger group
removal from the tripartite probe, subsequent rapid cleavage of
linker occurs so as to aﬀord reporter 2, which has distinct
spectral properties such that NQO1-positive cancer cells can be
imaged and identiﬁed with a positive-to-negative ratio of
∼500:1.
As seen in Figure 1, the spectroscopic properties of probe 1
and reporter 2 in buﬀered aqueous media are strikingly

Figure 2. Reduction-stimulated turning on of reporter 2. Time-course
ﬂuorescence (λex = 432 nm, λemis = 540 nm) from 10 μM probe 1 (pH
7.40, 0.1 M phosphate buﬀer) after reduction by 16 μM sodium
dithionite. The inset contains time-dependent spectra of 2 μM probe 1
upon reduction. T = 25 °C.

Reporter 2 is quickly turned on (t1/2 ∼6 min) under
physiologically relevant conditions, pointing to the rapid selfimmolative cleavage of the N-methyl-p-aminobenzyl alcohol
and CO2 loss8 to yield reporter 2; this occurs because of the
electron-rich character of the N-methyl-p-aminobenzyl alcohol
vs that of the more typically encountered p-aminobenzyl
alcohol linker. 8,17 Conversion was conﬁrmed by mass
spectrometry analysis of probe 1 solutions treated with
dithionite.9 On the basis of the relatively short time for the
turn-on process, the use of probe 1 should allow for detecting
the presence of NQO1 enzyme activity.
To evaluate the ability of human NAD(P)H:quinone
oxidoreductase-1 (hNQO1) to initiate the decloaking of
probe 1 and reveal free reporter 2 upon Q3PA trigger group
activation, we utilized the ﬂuorescent product formation
technique.18 Under in vitro conditions, solutions of probe 1
(2−60 μM) incubated with hNQO1 (40 μg) and its cofactor
NADH (100 μM) exhibited steady increases in ﬂuorescence,
suggesting a relatively fast rate of reporter 2 production; control
experiments with NADH alone did not yield signiﬁcant changes
in ﬂuorescence, a result in accord with that previously shown
for the Q3PA trigger group.10 In addition, the Q3PA trigger
group is stable to reduction/addition reactions in the presence
of glutathione and ascorbate as well as dithiothreitol.5

Figure 1. Absorbance and emission spectra of 2 μM probe 1 and
reporter 2 in pH 7.40, 0.1 M phosphate buﬀer. T = 25 °C.

diﬀerent, and these diﬀerences are attributed to the presence of
the quinone propionic acid trigger group (Q3PA), as well as the
carbamate connection between the N-methyl-p-aminobenzyl
alcohol, NMPABA, linker, and the naphthalimide ﬂuorophore.
The λreport
is red shifted roughly 50 nm in comparison to λprobe
abs
abs
probe
(432 nm vs 380 nm), as is λreport
emis vs λemis (532 nm vs 480 nm),
with both observations being in accord with the presence of the
electron-deﬁcient carbamate14 in probe 1. Interestingly, the
absorptivity of probe 1 at the maximum absorption wavelength
of reporter 2 is ∼5 times lower than that for reporter 2. The
Φprobe value of 0.002, which is 95 times less than Φreport = 0.19,9
is due to photoinduced electron transfer (PeT)15 quenching of
7576
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amide-linked napthalimide reporter, Q3NI.5 Wide-ﬁeld ﬂuorescence micrographs yielded similar results. Upon statistical
evaluation of the ﬂuorescence intensities in confocal images of
hNQO1-positive (35 samples) and hNQO1-negative (29
samples) cells like those in Figure 4, a value of 11 was found
for the positive-to-negative ratio (PNR).9 Similarly, for wideﬁeld ﬂuorescence images (33 positive samples/20 negative
samples), a PNR of 510 was observed.9 As a direct point for
comparison, a PNR of 23 was obtained for the Q3NI probe
using the same HT29(NQO1-positive)/H596(NQO1-negative) cells during wide-ﬁeld microscopy imaging experiments.5
Thus, the PNR value of ∼500 obtained with probe 1/reporter 2
is unprecedented in the context of our previous work with
identical cell lines, and this value can be improved in wide-ﬁeld
measurements by the use of a ﬁlter set (BCECF) that more
completely encompasses the emission proﬁle of reporter 2. It is
clear that the outcomes discussed here come about from the
exceedingly large diﬀerence in ﬂuorescence eﬃciency of
reporter 2 vs probe 1 (95-fold increase) that results from the
hNQO1-initiated removal of the trigger group quencher and
self-immolative linker, the very high ﬂuorescence eﬃciency of
reporter 2, the signiﬁcantly energy-shifted absorption maxima,
and the correspondingly lower molar absorptivity of probe 1 vs
reporter 2 at the excitation maximum of reporter 2. Also, the
energies over which probe 1/reporter 2 is excited/emits light
are shifted to the red by roughly 100 nm when compared to
those of the previously documented Q3NI probe,5 leading to a
signiﬁcantly decreased background (negative) signal.
In summary, we have presented the synthesis, properties, and
biological evaluation of a novel turn-on ﬂuorescent probe for
the cancer-linked enzyme NQO1. The discrimination of human
cells possessing NQO1, from those that do not, is achieved in a
highly selective fashion, which results from the dramatically
increased ﬂuorescence eﬃciency of the red-shifted reporter 2
that is generated only upon hNQO1 action on the trigger
group of probe 1. We are now using the ICT-tunable probe 1
and its variants to develop methods, including multiphoton
imaging routes,5 that allow for the identiﬁcation of hard-todetect NQO1-expressing cancerous tissues, as well as the
diversiﬁcation of disease targets20,21 for the activation of new
trigger groups. With regard to longer-term impacts, enzymeactivatable probes will play important roles as “intelligent”
imaging agents applied to the ﬂuorescence-assisted resection of
cancerous tissues22 and eﬃcacy studies of personalized
chemotherapy.23

Furthermore, hNQO2 plus its cofactor13 is ineﬀective at
releasing reporter 2. From the hNQO1 enzyme experiments,
the initial rate of reporter 2 formation, V (μmol min−1 mg
hNQO1−1), was calculated and then plotted as a function of
probe 1 concentration (Figure 3). Apparent kinetic parameters

Figure 3. Kinetics of human NQO1 (40 μg) with probe 1 (2−60 μM)
in pH 7.4, 0.1 M phosphate buﬀer. Values (n = 3) are the average ±1
sample standard deviation. The curve is the best ﬁt to the average data.
T = 25 °C.

were obtained by ﬁtting the data in Figure 3 to Michaelis−
Menten kinetics,19 namely, the Michaelis constant (Km) = 10.4
± 1.0 μM, maximum velocity (Vmax) = 0.00225 ± 0.00008
μmol min−1 mg hNQO1−1, catalytic constant (kcat) = 0.068 ±
0.002 min−1, and catalytic eﬃciency (kcat/Km) = 6.52 ± 0.67 ×
103 M−1 min−1. Also, there is no apparent inhibition of hNQO1
activity with the [probe 1] values studied. Thus, substantial
reporter 2 release occurs upon probe 1 interaction with
hNQO1 under physiologically relevant conditions.
To investigate the possibility of diﬀerentiating types of cancer
cells based on hNQO1 content (positive vs negative), we
exposed live hNQO1-positive and hNQO1-negative cells to
probe 1 under typical culture conditions (37 °C/CO 2
atmosphere). Confocal ﬂuorescence microscopy images of
hNQO1-positive colorectal cancer cells (HT29) incubated with
probe 1 indicated signiﬁcant probe 1 uptake and activation,
resulting in intense intracellular reporter 2 production.
However, hNQO1-negative nonsmall cell lung cancer cells
(H596) treated with probe 1 revealed minimal signal (Figure
4), pointing to the intracellular stability of probe 1 in NQO1negative cells, similar to what we have observed for another
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